The Technical Analyst
Research Solutions Inc [RSSS]
Exchange: NASDAQ Sector: Technology Industry: Software—Application
Research Solutions Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $3.00
America/New_York / 22 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 97.86 mill |
| EPS: | -0.0200 |
| P/E: | -150.00 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 32.62 mill |
| Avg Daily Volume: | 0.0631 mill |
| RATING 2024-04-22 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -150.00 | sector: PE -1.697 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -150.00 | industry: PE -81.55 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$2.65 (-11.64%) $-0.349 |
| Date: 2024-02-09 |
| Expected Trading Range (DAY) |
|---|
|
$ 2.78 - 3.22 ( +/- 7.30%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-20 | Derycz Peter | Sell | 40 402 | Common Stock |
| 2024-03-21 | Derycz Peter | Sell | 26 517 | Common Stock |
| 2024-03-22 | Derycz Peter | Sell | 2 576 | Common Stock |
| 2024-03-20 | Nurthen William | Sell | 29 472 | Common Stock |
| 2024-03-20 | Olivier Roy W | Sell | 32 265 | Common Stock |
| INSIDER POWER |
|---|
| -27.05 |
| Last 95 transactions |
| Buy: 2 079 301 | Sell: 2 081 612 |
Forecast:
16:00 - $3.01
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $3.01
Forecast 2: 16:00 - $3.01
Forecast 3: 16:00 - $3.01
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $3.00 (0.00% ) |
| Volume | 0.0274 mill |
| Avg. Vol. | 0.0631 mill |
| % of Avg. Vol | 43.49 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RSSS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RSSS
Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.
Last 10 Buy Signals
Latest Press Releases
2024-04-15 08:42:00 - Press Release
Research Solutions Unveils Ai Platform For Automated Clinical Trial Landscape Reports
Powerful ai, combined with comprehensive data, simplifies the discovery and synthesis of clinical trial information to accelerate innovation in the medical field henderson, nev. , april 15, 2024 /prnewswire/ -- research solutions (nasdaq: rsss), a trusted partner providing cloud-based workflow solutions to accelerate research for r&d-driven organizations, today launches their new clinical trial landscape software solution, making clinical trial information more accessible, insightful, and actionable.
2024-04-04 10:55:00 - Press Release
Heart Rhythm Clinical And Research Solutions And The Real World Evidence Consortium Launch Evercool Af Study On Attune Medical's Ensoetm®
Chicago--(business wire)--heart rhythm clinical and research solutions (hrcrs) and the real world evidence (rwe) consortium have enrolled the first patient in the review of procedural factors and outcomes after atrial fibrillation ablation with active esophageal cooling (evercool af) study. the study is part of a multi-center observational study evaluating the impact of proactive esophageal cooling on patient outcome, throughput, and experience in high volume centers. the rwe consortium consist.
2024-02-15 10:15:00 - Press Release
Research Solutions Launches Ai Platform To Automatically Create Technology Landscape Reports
Ai-powered software module enables production of reports in minutes to save months of manual analysis henderson, nev. , feb. 15, 2024 /prnewswire/ -- research solutions (nasdaq: rsss), a trusted partner providing cloud-based workflow solutions to accelerate research for r&d-driven organizations, today launches their new technology landscape module.
2024-02-08 16:05:00 - Press Release
Research Solutions Reports Fiscal Second Quarter 2024 Results
Reports 18.3% revenue increase and arr of $15.6 million henderson, nev. , feb. 8, 2024 /prnewswire/ -- research solutions, inc. (nasdaq: rsss), a trusted partner providing cloud-based workflow solutions to accelerate research for r&d-driven organizations, reported financial results for its fiscal second quarter ended december 31, 2023.
2024-01-31 14:12:00 - Press Release
Research Solutions To Announce Second Quarter Fiscal 2024 Results On Thursday, February 8, 2024
Henderson, nev. , jan. 31, 2024 /prnewswire/ -- research solutions, inc. (nasdaq: rsss), a pioneer in providing cloud-based workflow solutions for r&d driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 second quarter ended december 31, 2023, on thursday, february 8, 2024, at 5:00 p.m.
Latest News
2024-03-21 08:20:09 - InvestorPlace
3 Millionaire-Maker AI Stocks to Buy Before Wall Street Does
Nvidia's (NASDAQ: NVDA ) recent AI conference showcased some impressive new technology, including the company's expensive new AI chip that purportedly outperforms all other AI chips on the market. However, the hype did not translate into a meaningful stock price increase, as many investors believe the company's growth potential is already priced into its lofty market capitalization.
2024-03-05 10:46:41 - Zacks Investment Research
Has Research Solutions (RSSS) Outpaced Other Industrial Products Stocks This Year?
Here is how Research Solutions Inc. (RSSS) and AB SKF (SKFRY) have performed compared to their sector so far this year.
2024-02-08 23:23:06 - Seeking Alpha
Research Solutions, Inc. (RSSS) Q2 2024 Earnings Call Transcript
2024-01-31 14:12:00 - PRNewsWire
Research Solutions to Announce Second Quarter Fiscal 2024 Results on Thursday, February 8, 2024
HENDERSON, Nev. , Jan. 31, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 second quarter ended December 31, 2023, on Thursday, February 8, 2024, at 5:00 p.m.
2024-01-22 09:00:00 - PRNewsWire
Research Solutions to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference on Wednesday, January 24
HENDERSON, Nev. , Jan. 22, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that Roy W.
2023-11-11 04:59:07 - Seeking Alpha
Research Solutions, Inc. (RSSS) Q1 2024 Earnings Call Transcript
2023-11-10 08:30:00 - PRNewsWire
Research Solutions to Participate in Pair of Investor Conferences
HENDERSON, Nev. , Nov. 10, 2023 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, announced it will participate in a pair of investor conferences.
2023-10-26 10:44:00 - PRNewsWire
Research Solutions to Announce First Quarter Fiscal 2024 Results on Thursday, November 9, 2023
HENDERSON, Nev. , Oct. 26, 2023 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 first quarter ended September 30, 2023, on Thursday, November 9, 2023, at 5:00 p.m.
2023-09-13 19:17:09 - Seeking Alpha
Research Solutions, Inc. (RSSS) Q4 2023 Earnings Call Transcript
Research Solutions, Inc. (NASDAQ:RSSS ) Q4 2023 Earnings Call Transcript September 13, 2023 5:00 PM ET Company Participants Steven Hooser - Investor Relations Roy W. Olivier - President and Chief Executive Officer Bill Nurthen - Chief Financial Officer Conference Call Participants Richard Baldry - Roth Capital Allen Klee - Maxim Group Peter Rabover - Artko Capital Operator Good afternoon, and welcome to the Research Solutions Fourth Quarter 2023 Earnings Conference Call.
2023-09-13 18:47:23 - Zacks Investment Research
Research Solutions Inc. (RSSS) Surpasses Q4 Earnings and Revenue Estimates
Research Solutions Inc. (RSSS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.02 per share a year ago.